Bankrupt 23Andme is facing a lawsuit for her plans to sell client genetic information.
Twenty -seven states and Colombia district took legal action this week against 23rds in the US bankruptcy court for the eastern district of Misuri, the court that oversees the bankruptcy procedures of chapter 11 that the genetic testing enterprise entered earlier during the year.
States claim that 23 ages has no right to sell their client genetic identity to the highest bidder “unless the company” first obtained[s] Express informed consent for the transaction/transfer proposed by each impact consumer. “
They want the bankruptcy court to decide on “if and to what extent” the genetic testing company can “sell and transfer to a third party such intimate data of the client without first receiving the informed consent of its clients”, according to the file.
In Philing, states said they “were not in violation of any sales”, but “claim that Express, informing each customer’s consent is necessary before any data transfer is made”.
Lawyers who filed a lawsuit represent Arizona, Colorado, Connecticut, Colombia District, Florida, Illinois, Kansas, Kentucky, Luiziana, Maine, Michigan, Minnesota, New Hampshire, New Mexico, New York, North Carolina, Oklahoma. Carolina, South Dakota, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.
“23 ORTHER CANNOT ACCESS MILLION OF PERSONAL GENETICS OF PEOPLE without their consent,” New York Attorney General Lettia James said in a statement.
“New Yorkers and many others all over the country entrusted 23As with their private information, and they have the right to know what to do with their information.”
A spokesman for 23rdme told Fox Business that the arguments made by Atttorneys General in the lawsuit were “without merit”.
“The sale is permitted under 23rds of the Intimacy Police and the law of application,” the spokesman said.
“We demanded that every bidder approve our police and respect the law of application as a condition to participate in our sales process. Consumers will continue to have the same rights and protection in the hands of the winning bidder.”
The remaining bidders, a regeneration pharmaceutical and a TTAM research institute, “have been committed to respecting 23 -way police of intimacy, and will continue to operate 23 -OR as always operated”, according to the 23rd spokesman.
In May, New York -based regeneration announced that the successful auction bidder had been appointed to “essentially all” 23 -aging assets with a $ 256 million offer.
23Andme then received a $ 305 million offer from the TTAM Institute of Research founded by Anne Wojcicki, setting the stage for another auction.
The genetic test company entered Chapter 11 of bankruptcy on March to facilitate a sale of its business.
In its bankruptcy petition, the company valued a range of 100 million to $ 500 million for its assets, with liabilities estimated in the same range.
23 ORDER was originally founded in 2006.
#States #legal #actions #23Andme #Atttempts #sell #clients #genetic #information #bankruptcy
Image Source : nypost.com